How to buy Praxis Precision Medicine stock (Praxis Precision Medicine)

Praxis Precision Medicine is a biotechnology business based in the US. Praxis Precision Medicine shares (PRAX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $77.25 – an increase of 6.05% over the previous week. Praxis Precision Medicine employs 82 staff and has a trailing 12-month revenue of around $1.6 million.

Our top picks for where to buy Praxis Precision Medicines Inc stock

Buy Praxis Precision Medicine stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Praxis Precision Medicine stock price (NASDAQ: PRAX)

Use our graph to track the performance of PRAX stocks over time.

Praxis Precision Medicine shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$77.25
52-week range	$19.61 - $86.93
50-day moving average more info button	$72.72
200-day moving average more info button	$56.91
Wall St. target price	$162.60
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-9.17

Is it a good time to buy Praxis Precision Medicine stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Praxis Precision Medicine price performance over time

Historical closes compared with the close of $77.25 from 2024-12-24

1 week (2024-12-19)	6.05%
1 month (2024-11-26)	-3.03%
3 months (2024-09-26)	33.67%
6 months (2024-06-26)	90.88%

1 year (2023-12-26)	239.71%
2 years (2022-12-23)	112.81%
3 years (2021-12-23)	309.15
5 years (2019-12-22)	N/A

Praxis Precision Medicine financials

Revenue TTM	$1.6 million
Gross profit TTM	$0
Return on assets TTM	-39.2%
Return on equity TTM	-64.34%
Profit margin	0%
Book value	$21.52
Market Capitalization more info button	$1.3 billion

TTM: trailing 12 months

Praxis Precision Medicine share dividends

We're not expecting Praxis Precision Medicine to pay a dividend over the next 12 months.

You may also wish to consider:

• Abbott Laboratories (ABT.US) (2.11% forward annual dividend yield)

Have Praxis Precision Medicine's shares ever split?

Praxis Precision Medicine's shares were split on a 1:15 basis on 28 November 2023 . So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Praxis Precision Medicine shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Praxis Precision Medicine shares which in turn could have impacted Praxis Precision Medicine's share price.

Praxis Precision Medicine share price volatility

Over the last 12 months, Praxis Precision Medicine's shares have ranged in value from as little as $19.61 up to $86.93. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Praxis Precision Medicine's is 2.687. This would suggest that Praxis Precision Medicine's shares are significantly more volatile than the average for this exchange and represent a higher risk.

To put Praxis Precision Medicine's beta into context you can compare it against those of similar companies.

• Abbott Laboratories (ABT.US): 0.722
• Inovio Pharmaceuticals (INO.US): 0.833
• Moderna (MRNA.US): 1.69

Praxis Precision Medicine overview

Praxis Precision Medicines, Inc. , a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is developing ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase III clinical trial for the treatment of essential tremor; PRAX-562 for the treatment of pediatric patients with developmental and epileptic encephalopathies (DEE); and PRAX-628 to treat focal epilepsy. The company also develops PRAX-222 for the treatment of pediatric patients with early-onset SCN2A-DEE; PRAX-020 to treat KCNT1 related epilepsies; PRAX-080 for the treatment of PCDH19; and PRAX-090 and PRAX-100 for SYNGAP1 and SCN2A-LoF. It has a license agreement with RogCon Inc. ; a research collaboration and license agreement with Ionis Pharmaceuticals, Inc. ; a strategic collaboration and license agreement with UCB Biopharma SRL; and collaboration with The Florey Institute to develop three novel ASOs.

Frequently asked questions

What percentage of Praxis Precision Medicine is owned by insiders or institutions?
Currently 0.245% of Praxis Precision Medicine shares are held by insiders and 104.013% by institutions. How many people work for Praxis Precision Medicine?
Latest data suggests 82 work at Praxis Precision Medicine. When does the fiscal year end for Praxis Precision Medicine?
Praxis Precision Medicine's fiscal year ends in December. Where is Praxis Precision Medicine based?
Praxis Precision Medicine's address is: 99 High Street, Boston, MA, United States, 02110 What is Praxis Precision Medicine's ISIN number?
Praxis Precision Medicine's international securities identification number is: US74006W1080